Metastatic Breast Cancer
News
Polygenic breast cancer risk scores strive to overcome racial bias
Efforts...
Article
Therapeutic Approaches in Advanced Breast Cancer
Dr Susan Domchek, from the University of Pennsylvania, discusses the importance of identifying molecular characteristics of metastatic breast...
News
Key strategies for managing breast cancer brain metastases
Because our systemic therapies in breast cancer are...
Conference Coverage
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancer
Conference Coverage
ASCO 2021: Breast cancer sessions not to miss
Conference Coverage
IL-6 levels predict distant breast cancer recurrence
Conference Coverage
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first year
Conference Coverage
Endocrine therapy benefits in premenopausal breast cancer differ by molecular risk
News
Evolving strategies in sequencing for HER2+ MBC therapy
In a 12-month window, the FDA approved four agents targeting HER2-positive MBC.
News
New targeted treatments are major advances for HER2-positive breast cancer